University Of British Columbia

The University of British Columbia (UBC) is a public research university in Vancouver, Canada that provides a wide range of research and analytical services to U.S. federal agencies through contracts and grants. As one of Canada's top universities, UBC leverages its world-class research facilities and faculty expertise to support U.S. government scientific and medical research initiatives across multiple disciplines. UBC has extensive capabilities in areas such as biomedical research, clinical trials, data analysis, environmental studies, and materials science. The university operates as "Research Services" when contracting with U.S. agencies, allowing it to efficiently manage and execute federal awards.

Through federal contracts, UBC has provided specialized research and testing services valued at over $17 million since 2019. Recent contract work includes a $206,140 award from the U.S. Geological Survey for radiogenic isotope analysis of volcanic samples, a $23,000 award for zircon analyses, and a $17,030 award from the National Institute on Drug Abuse to measure steroid levels via mass spectrometry. Other contract work has involved wood chemical analysis for the Forest Service, bulk rock solution analysis for geological studies, and data abstraction and statistical analysis for cancer research. UBC primarily serves as a prime contractor on these awards, which are typically structured as firm-fixed price purchase orders with no set-aside designations.

UBC has received over $50 million in U.S. federal grant awards since 2019 to conduct medical and scientific research. Major grant programs include multiple awards from the Department of Defense for spinal cord injury and traumatic brain injury research, as well as grants from the National Institutes of Health for studies on Alzheimer's disease, prostate cancer, and infectious diseases. UBC often partners with U.S. universities and medical centers on these grants, serving as either the prime recipient or a subrecipient. For example, UBC received a $2.5 million grant from the Defense Health Agency to study spinal cord injury treatments and a $1.7 million NIH grant to investigate biomarkers for prostate cancer. These grants allow UBC to leverage its research capabilities and collaborate with U.S. institutions to advance medical knowledge and treatments.